Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Voyager Therapeutics Inc VYGR

Voyager Therapeutics, Inc. is a biotechnology company focused on advancing neurogenetic medicines. The Company’s pipeline includes programs for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple other diseases of the central nervous system. Many of its programs are derived from its TRACER AAV capsid discovery platform, which is used to generate novel... see more

Recent & Breaking News (NDAQ:VYGR)

Voyager Therapeutics Announces Positive Interim Results from Phase 1b Trial of VY-AADC01 for Advanced Parkinson’s Disease

GlobeNewswire December 7, 2016

REGENXBIO and Voyager Therapeutics Announce Exercise of Options for Rights to NAV Vectors

GlobeNewswire November 29, 2016

Voyager Therapeutics and REGENXBIO Announce Exercise of Options for Rights to NAV Vectors

GlobeNewswire November 29, 2016

Voyager Therapeutics Provides Third Quarter 2016 Investor Update

GlobeNewswire November 10, 2016

Voyager Therapeutics to Host Third Quarter 2016 Investor Update Call

GlobeNewswire November 1, 2016

Voyager Therapeutics Announces Planned Transition Process for Chief Financial Officer

GlobeNewswire October 18, 2016

Voyager Therapeutics Licenses Novel Gene Therapy Capsids from the California Institute of Technology

GlobeNewswire September 15, 2016

Voyager Therapeutics Aligns With CHDI Foundation TO Develop Novel Gene Therapy For Huntington's Disease

Benzinga.com  September 12, 2016

Voyager Therapeutics and CHDI Foundation Collaborate to Develop Novel Gene Therapy for Huntington’s Disease

GlobeNewswire September 12, 2016

Voyager Therapeutics to Attend Upcoming Investor Conferences

GlobeNewswire August 12, 2016

Voyager Therapeutics Provides Second Quarter 2016 Investor Update

GlobeNewswire August 11, 2016

Voyager Therapeutics Initiates Third Cohort in Ongoing Phase 1b Clinical Trial of VY-AADC01 in Advanced Parkinson’s Disease

GlobeNewswire August 9, 2016

Voyager Therapeutics to Host Second Quarter 2016 Investor Update Call

GlobeNewswire August 4, 2016

Voyager Therapeutics Reveals Interim Phase 1b Surgical Results For VY-AADC01 In Advanced Parkinson's Disease

Benzinga.com  June 22, 2016

Voyager Therapeutics Announces Interim Phase 1b Surgical Results for VY-AADC01 in Advanced Parkinson’s Disease

GlobeNewswire June 22, 2016